TABAK, Ö. F. Et Al. 2018. Direct-Acting Antiviral are safe and effective in cirrhotic hepatitis C infection patients: Real-life data from Turkey. TASL – EASL Educational Conference , (İstanbul, Turkey).

TABAK, Ö. F., ÖZTOPRAK ÇUVALCI, N., KURTARAN, B., ÖNLEN, Y., SARI, N. D., İNCE, N., ... ESEN, Ş.(2018). Direct-Acting Antiviral are safe and effective in cirrhotic hepatitis C infection patients: Real-life data from Turkey . TASL – EASL Educational Conference, İstanbul, Turkey

TABAK, ÖMER Et Al. "Direct-Acting Antiviral are safe and effective in cirrhotic hepatitis C infection patients: Real-life data from Turkey," TASL – EASL Educational Conference, İstanbul, Turkey, 2018

TABAK, ÖMER F. Et Al. "Direct-Acting Antiviral are safe and effective in cirrhotic hepatitis C infection patients: Real-life data from Turkey." TASL – EASL Educational Conference , İstanbul, Turkey, 2018

TABAK, Ö. F. Et Al. (2018) . "Direct-Acting Antiviral are safe and effective in cirrhotic hepatitis C infection patients: Real-life data from Turkey." TASL – EASL Educational Conference , İstanbul, Turkey.

@conferencepaper{conferencepaper, author={ÖMER FEHMİ TABAK Et Al. }, title={Direct-Acting Antiviral are safe and effective in cirrhotic hepatitis C infection patients: Real-life data from Turkey}, congress name={TASL – EASL Educational Conference}, city={İstanbul}, country={Turkey}, year={2018}}